
HAYA Positioned for Growth After Moving U.S. HQ
LA JOLLA – Precision medicines company HAYA Therapeutics, SA is in position to substantially increase its rate of growth after expanding its partnership with Eli Lilly and Co. (NYSE: LLY), moving to an expanded headquarters and closing an eight-figure …